US Patent Issued to JELLAGEN, MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH on Feb. 24 for "Jellyfish collagen use" (British, American Inventors)

ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,558,402, issued on Feb. 24, was assigned to JELLAGEN PTY LTD (Sterling, Great Britain) and MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (Rochester, Minn.).

"Jellyfish collagen use" was invented by Andrew Mearns Spragg (Stirling, Great Britain), Dale Ekbom (Rochester, Minn.) and Serban San-Marina (Rochester, Minn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to jellyfish collagen for use in the treatment of vocal fold paralysis."

The patent was filed on June 15, 2021, under Application No. 18/010,762.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Par...